Rheumatology, coded right.

99214 is the workhorse of primary care and most outpatient subspecialties. Use it when at least one of these is true: two or more chronic problems with progression, treatment changes, or side effects; one undiagnosed new problem with uncertain prognosis; one acute illness with systemic symptoms; or prescription drug management at any complexity. Prescription drug management on its own satisfies the moderate-risk element, which is why straightforward chronic disease follow-ups with a med adjustment routinely clear the 99214 bar. Time-based alternative is 30 to 39 minutes of total time on the date of the encounter. Pick the method that supports the strongest note: encounters with prescription changes are usually cleaner under MDM; encounters with extensive counseling or care coordination are usually cleaner under time.

Use 99215 when the encounter genuinely required high-complexity decision-making: severe exacerbation or decompensation of a chronic illness, an acute or chronic illness or injury that poses a threat to life or bodily function, decision regarding hospitalization, drug therapy requiring intensive monitoring for toxicity, or extensive comorbidity management driving a high-risk decision. Real examples: a CHF patient with new bilateral leg edema and dyspnea where you considered emergency admission; a new-onset AFib with RVR you elected to manage outpatient with same-day rate-control titration; an oncology patient with febrile neutropenia. Time-based alternative is 40 to 54 minutes of total time on the date of the encounter.

G2211 is the continuity add-on. Append it to an office E/M (99202 through 99215) under one of two conditions: you are the continuing focal point for all of the patient's health care (the primary-care framing), OR you are the ongoing care provider for a patient's single serious condition or a complex condition (the subspecialty framing). Common eligible scenarios: a routine primary care follow-up for chronic disease management; an endocrinology continuity visit for diabetes; an oncology survivorship visit; a rheumatology disease-modifying-medication monitoring visit; a nephrology follow-up for CKD progression. Ineligible scenarios: one-time consults, urgent care visits, hospital follow-up where you are not the longitudinal provider, and visits where modifier 25 is appended to the primary E/M (explicitly prohibited).

Major joint injection or aspiration without US guidance.

Major joint injection with US guidance and permanent recording.

Intermediate joint injection without US guidance.

Intermediate joint injection with US guidance and permanent recording.

De Quervain's, trigger finger, lateral epicondyle, plantar fascia injections.

Trigger point injection in 1 or 2 muscles (any number of injections within those muscles).

Trigger point injection in 3 or more muscles.